Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases.

Cancer Cell Int · 2022 · PMC9019971 · PMID 35439996

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In our previous study, we found that the expression level of the glycoprotein AACT and its GlcNAcylation level were decreased in the serum of patients with early-stage NSCLC, and were especially significantly decreased in stage IA, but AACT and its GlcNAcylation levels were restored and presented an increasing trend in late-stage NSCLC [ 16 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.